日韩欧美 a级,国产又色又爽又刺激在线观看,偷偷色噜狠狠狠狠的777米奇,浮妇高潮喷白浆视频

產(chǎn)品中心

Product center

鹽酸阿霉素 USP級,98%(HPLC)

DOX

源葉
S17092
25316-40-9
C27H29NO11·HCl
579.98
MFCD00077757
品牌 貨號 產(chǎn)品規(guī)格 價格(RMB) 庫存(上海) 北京 武漢 南京 購買數(shù)量
源葉 S17092-25mg USP級,98%(HPLC) ¥120.00元 >10 - 2 3
源葉 S17092-100mg USP級,98%(HPLC) ¥190.00元 >10 4 - 2
源葉 S17092-500mg USP級,98%(HPLC) ¥690.00元 9 - - 2
源葉 S17092-5g USP級,98%(HPLC) ¥3980.00元 1 - - -
產(chǎn)品介紹 參考文獻(135篇) 質檢證書(COA) 摩爾濃度計算器 相關產(chǎn)品

產(chǎn)品介紹

Doxorubicin (Hydroxydaunorubicin) hydrochloride 是一種具有細胞毒性的蒽環(huán)類抗生素,是一種抗癌化療試劑。Doxorubicin hydrochloride 是一種有效的人類 DNA topoisomerase I 和 topoisomerase II 抑制劑,IC50 分別為 0.8 μM 和 2.67 μM。Doxorubicin hydrochloride 可降低 AMPK及其下游靶蛋白乙酰輔酶 A 羧化酶的磷酸化。還可誘導凋亡 (apoptosis) 和自噬。

熔點: 216℃
沸點: 810.3℃ at 760 mmHg
外觀: 橙色至紅色至紅棕色粉末
溶解性: DMSO  :  35.71  mg/mL  (61.57  mM;  ultrasonic  and  warming  and  heat  to  60°C)

H2O  :  20  mg/mL  (34.48  mM;  Need  ultrasonic)溶液不穩(wěn)定建議現(xiàn)配現(xiàn)用
敏感性: 對光和濕度敏感
儲存條件: 2-8℃
用途: 本品僅供科研,不得用于其它用途。
注意: 部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。

參考文獻(135篇)

130. [IF=3.9] Mingshuang Zhang et al."Biodegradable silk fibroin membranes for potential localized treatment of melanoma: optimized preparation and in vitro study."Biomedical Materials.2024 Dec;20(1):015025 129. [IF=3.3] Yinzhuang Zhang et al."VPO1 Promotes Programmed Necrosis of Cardiomyocytes in Rats with Chronic Heart Failure by Upregulating CYLD."Frontiers in Bioscience-Landmark.2024 Dec;29(12):425 128. [IF=5.6] Lu Yang et al."Long Afterglow Hybrid Nanoplatform for Integrated NIR-Ⅱ Imaging Diagnosis and Triple-synergistic Treatment of Choroidal Melanoma."TALANTA.2024 Dec;:127492 127. [IF=4.1] Tianxin Weng et al."Chemotherapy-phototherapy combination drugs co-loaded by a DNA tetrahedron to overcome drug resistance: The influence of different binding properties of doxorubicin and idarubicin and pH response."DYES AND PIGMENTS.2025 Apr;235:112630 126. [IF=6.6] Zhaoming Guo et al."Ginger-Derived Exosome-Like Nanoparticles Loaded With Indocyanine Green Enhances Phototherapy Efficacy for Breast Cancer."International Journal of Nanomedicine.2025 Jan;20:1147-1169 125. [IF=10.6] Wu Can et al."Trypsin-instructed bioactive peptide nanodrugs with cascading transformations to improve chemotherapy against colon cancer."JOURNAL OF NANOBIOTECHNOLOGY.2025 Dec;23(1):1-20 124. [IF=3.5] Xinze Liu et al."Ginsenoside CK Promotes Cell Apoptosis via Regulating P53 Signal Pathway in Non-Small Cell Lung Cancer."DRUG DEVELOPMENT RESEARCH.2025 Feb;86(2):e70050 123. [IF=5.3] Huihui Li et al."Oncolytic polymer-mediated combretastatin A4 phosphate delivery for enhancing vascular disrupting therapy."INTERNATIONAL JOURNAL OF PHARMACEUTICS.2025 Apr;674:125438 122. [IF=17.3] Hao Wang et al."A wearable transdermal device for on-demand drug delivery."Matter. 121. [IF=4.8] Bohuai Tang et al."Doxorubicin promotes NK cell dysfunction and induces acute liver injury through kynurenine-AhR axis."INTERNATIONAL IMMUNOPHARMACOLOGY.2025 Apr;153:114489 120. [IF=4] Jie Liu et al."Hairpin DNA-functionalized gold nanoparticles for diagnostic imaging and overcoming doxorubicin resistance: enhanced drug loading and cytotoxicity based on thermodynamic guidance."JOURNAL OF MOLECULAR STRUCTURE.2025 Apr;:142264 119. [IF=8.7] Liying Xiao et al."Targeting drug cocktail hydrogel platform for inhibiting tumor growth and metastasis."Materials Today Bio.2025 Jun;32:101798 118. [IF=1.7] Zuo Xu-Han et al."Thrombopoietin ameliorates doxorubicin-induced toxicities in H9c2 myocardiocytes by inhibiting oxidative stress through the SIRT1/p38 MAPK signaling pathway."Asian Pacific Journal of Tropical Biomedicine.2024 Sep;14(9):410 117. [IF=4.7] Zou Hai et al."Cynaroside regulates the AMPK/SIRT3/Nrf2 pathway to inhibit doxorubicin-induced cardiomyocyte pyroptosis."Journal of Zhejiang University-SCIENCE B.2024 Sep;:1-17 116. [IF=10.6] Chen Jianmei et al."Ultrasound targeted microbubble destruction assisted exosomal delivery of siHmox1 effectively inhibits doxorubicin-induced cardiomyocyte ferroptosis."JOURNAL OF NANOBIOTECHNOLOGY.2024 Dec;22(1):1-13 115. [IF=3.4] Zhilin Jin et al."Determination of doxorubicin in plasma and tissues of mice by UPLC-MS/MS and its application to pharmacokinetic study."Heliyon.2024 Aug;10: 114. [IF=4.4] Qu Minmin et al."Assessing genotoxic effects of chemotherapy agents by a robust in vitro assay based on mass spectrometric quantification of γ-H2AX in HepG2 cells."Frontiers in Pharmacology.2024 Jun;15: 113. [IF=4.7] Jiping Zhang et al."4-Deoxy-ε-Pyrromycinone: A Promising Drug/Lead Compound to Treat Tumors."Drug Design Development and Therapy.2024; 18: 2367–2379 112. [IF=4.7] Weihui Kong et al."Hyperosmotic cold shock mouse melanoma cells encapsulated with doxorubicin for targeted treatment of melanoma."Frontiers in Oncology".2024; 14: 1403719 111. [IF=7.5] Jaili Li et al."Cardioprotective potentials of myricetin on doxorubicin-induced cardiotoxicity based on biochemical and transcriptomic analysis."BIOMEDICINE & PHARMACOTHERAPY".2024 Jun;175:116748 110. [IF=8] Wenjie Xie et al."A Unique Approach: Biomimetic Graphdiyne-Based Nanoplatform to Treat Prostate Cancer by Combining Cuproptosis and Enhanced Chemodynamic Therapy."International Journal of Nanomedicine.10.2147/IJN.S455355 109. [IF=5.4] Yunfeng Di et al."Mass Production of Rg1-Loaded Small Extracellular Vesicles Using a 3D Bioreactor System for Enhanced Cardioprotective Efficacy of Doxorubicin-Induced Cardiotoxicity."Pharmaceutics".2024 May;16(5):593 108. [IF=8.2] Jingtong Wang et al."Gelatin nanocarriers assembled by a self-immolative cross-linker for targeted cancer therapy."INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES".2024 May;268:131722 107. [IF=3.3] Pinggui Chen et al."Porphyrin-based covalent organic frameworks as doxorubicin delivery system for chemo-photodynamic synergistic therapy of tumors."Photodiagnosis and Photodynamic Therapy".2024 Apr;46:104063 106. [IF=3.7] Rong-Kun Liu et al."Efficient construction of multi-stimuli responsive colloidosomes for intelligent transmembrane transport."AICHE JOURNAL".2024 Mar;:e18441 105. [IF=3.9] Xiaoyun Huang et al."Hetastarch-stabilized polypyrrole with hyperthermia-enhanced release and catalytic activity for synergistic antitumor therapy."RSC Advances".2024 Mar;14(12):8445-8453 104. [IF=5.4] Xinhe Liu et al."Yeast-Controlled Double-Shelled CaCO3/CaF2 Hollow Nanospheres with Hierarchically Porous for Sustained pH-Sensitive Drug Release."CHINESE JOURNAL OF CHEMISTRY".2024 Mar;: 103. [IF=3.6] Bin Xu et al."Role of glutaminyl-peptide cyclotransferase in breast cancer doxorubicin sensitivity."CANCER BIOLOGY & THERAPY.10.1080/15384047.2024.2321767 102. [IF=3.8] Han Song et al."Synthesis of drug-loaded H-ZIF-8@CaCO3-PEG nanocarrier for synergistic therapy."INORGANIC CHEMISTRY COMMUNICATIONS".2024 Apr;162:112225 101. [IF=4.6] Liying Xiao et al."Silk Nanofiber Carriers for both Hydrophilic and Hydrophobic Drugs to Achieve Improved Combination Chemotherapy."MACROMOLECULAR BIOSCIENCE.2024 Jan;:2300523 100. [IF=12.4] Xinxin Hang et al."A Nano-Electroporation-DNA Tensioner Platform Enhances Intracellular Delivery and Mechanical Analysis Toward Rapid Drug Assessment."Small Methods.2023 Nov;:2300915 99. [IF=3.9] Jia Jia et al."Efficient Construction of pH-Stimuli-Responsive Colloidosomes with High Encapsulation Efficiency."LANGMUIR.2023;XXXX(XXX):XXX-XXX 98. [IF=4.6] Fei Zhou et al."Inhibiting autophagy to boost antitumor immunity with tetramethylpyrazine-loaded and PD-L1-targeting Liposomal Nanoparticles."EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES.10.1016/j.ejps.2023.106581 97. [IF=7.5] Haohao Wang et al."Albumin nanoparticles and their folate modified counterparts for delivery of a lupine derivative to hepatocellular carcinoma."BIOMEDICINE & PHARMACOTHERAPY.10.1016/j.biopha.2023.115485 96. [IF=2.9] Cai Tie et al."Liposomal doxorubicin and free doxorubicin in vivo quantitation method developed on CE-LIF and its application in pharmacokinetic analysis."ELECTROPHORESIS.2023 Aug;44(17-18):1361-1368 95. [IF=8.2] Xinyu Li et al."Thermodynamic and cellular studies of doxorubicin/daunorubicin loaded by a DNA tetrahedron for diagnostic imaging, chemotherapy, and gene therapy."INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES.2023 Aug;:126245 94. [IF=14] Zhen Ya et al."Focused acoustic vortex-mediated sonochemotherapy for the amplification of immunogenic cell death combined with checkpoint blockade to potentiate cancer immunotherapy."BIOMATERIALS.2023 Oct;301:122278 93. [IF=6] Ronghui Li et al."Nitrogen-doped carbon dots for doxorubicin-targeted delivery and two-photon cell imaging."Arabian Journal of Chemistry.2023 Jun;:105067 92. [IF=9.5] Ge Li et al."Multi-Enzyme Cascade-Triggered Nitric Oxide Release Nanoplatform Combined with Chemo Starvation-like Therapy for Multidrug-Resistant Cancers."ACS Applied Materials & Interfaces.2023;XXXX(XXX):XXX-XXX 91. [IF=16.6] Fan Shengjie et al."Pregnane X receptor agonist nomilin extends lifespan and healthspan in preclinical models through detoxification functions."Nature Communications.2023 Jun;14(1):1-23 90. [IF=8.008] Yu Liu et al."Microfluidic Gradient Culture Arrays for Cell Pro-oxidation Analysis Using Bipolar Electrochemiluminescence."ANALYTICAL CHEMISTRY.2023;95(21):8376–8383 89. [IF=2.525] Mo Jingwen et al."Aptamer-based Upconversion Fluorescence Sensor for Doxorubicin Detection."JOURNAL OF FLUORESCENCE.2023 Mar;:1-9 88. [IF=5.307] Li Zhang et al."Synthesis of structurally diverse derivatives of aconitine-type diterpenoid alkaloids and their anti-proliferative effects on canine breast cancer cells."BIOORGANIC CHEMISTRY.2023 Jun;135:106501 87. [IF=10.383] Xijian Chen et al."A Smart Benzothiazole-Based Conjugated Polymer Nanoplatform with Multistimuli Response for Enhanced Synergistic Chemo-Photothermal Cancer Therapy."ACS Applied Materials & Interfaces.2023;15(13):16343–16354 86. [IF=0] Xue Wang et al."Silk Nanocarrier with Tunable Size to Improve Transdermal Capacity for Hydrophilic and Hydrophobic Drugs."ACS Applied Bio Materials.2023;XXXX(XXX):XXX-XXX 85. [IF=11.092] Fei Zhou et al."A Novel Tri-functional Liposome Re-educates “Cold Tumor” and Abrogates Tumor Growth by Synergizing Autophagy Inhibition and PD-L1 Blockade."Advanced Healthcare Materials.2023 Jan;:2202757 84. [IF=4.326] Manting Wang et al."Surfactant-Free Synthesis of PNIPAM-Based Smart Microgels for Drug Delivery Using a High-Gravity Rotating Packed Bed."INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH.2022;61(49):17866–17875 83. [IF=8.025] Tianxin Weng et al."A pH-sensitive DNA tetrahedron for targeted release of anthracyclines: Binding properties investigation and cytotoxicity evaluation."INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES.2022 Dec;223:766 82. [IF=9.417] Pengcheng Hu et al."Tumor microenvironment responsive-multifunctional nanocomposites knotted injectable hydrogels for enhanced synergistic chemodynamic and chemo-photothermal therapies."MATERIALS & DESIGN.2023 Jan;225:111429 81. [IF=5.062] Min Jiang et al."A novel polyphyllin I-based liposome delivery system sensitizes hepatic carcinoma to doxorubicin via cholesterol modulation."JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY.2022 Oct;:103925 80. [IF=5.215] Yin Huang et al."Plasma Pharmacokinetics and Tissue Distribution of Doxorubicin in Rats following Treatment with Astragali Radix."Pharmaceuticals.2022 Sep;15(9):1104 79. [IF=9.429] Zhang Bing et al."The anti-tumor and renoprotection study of E-[c(RGDfK)2]/folic acid co-modified nanostructured lipid carrier loaded with doxorubicin hydrochloride/salvianolic acid A."JOURNAL OF NANOBIOTECHNOLOGY.2022 Dec;20(1):1-20 78. [IF=10.947] Yang Shi et al."Light-Induced Cold Marangoni Flow for Microswarm Actuation: From Intelligent Behaviors to Collective Drug Delivery."Laser & Photonics Reviews.2022 Sep;:2200533 77. [IF=6.525] Lixia Chen et al."A Novel Diosgenin-Based Liposome Delivery System Combined with Doxorubicin for Liver Cancer Therapy."Pharmaceutics.2022 Aug;14(8):1685 76. [IF=8.039] Haohao Wang et al."Seco-Lupane Triterpene Derivatives Induce Ferroptosis through GPX4/ACSL4 Axis and Target Cyclin D1 to Block the Cell Cycle."JOURNAL OF MEDICINAL CHEMISTRY.2022;XXXX(XXX):XXX-XXX 75. [IF=15.153] Huichao Xie et al."Erythrocyte Membrane-Coated Invisible Acoustic-Sensitive Nanoparticle for Inducing Tumor Thrombotic Infarction by Precisely Damaging Tumor Vascular Endothelium."Small 74. [IF=3.772] Qin Zhu et al."L-norvaline affects the proliferation of breast cancer cells based on the microbiome and metabolome analysis."JOURNAL OF APPLIED MICROBIOLOGY 73. [IF=30.849] Yiyuan Zhang et al."Biocompatible Vibration-Actuated Omni-Droplets Rectifier with Large Volume Range Fabricated by Femtosecond Laser."Advanced Materials. 2021 Dec 05 72. [IF=9.229] Pingping Xu et al."High-Performance Smart Hydrogels with Redox-Responsive Properties Inspired by Scallop Byssus."Acs Appl Mater Inter. 2021;XXXX(XXX):XXX-XXX 71. [IF=4.939] Li Wu et al."Preparation of a Self-Assembled Rhein–Doxorubicin Nanogel Targeting Mitochondria and Investigation on Its Antihepatoma Activity."Mol Pharmaceut. 2021;XXXX(XXX):XXX-XXX 70. [IF=4.749] Liying Xiao et al."Silk Nanocarrier Size Optimization for Enhanced Tumor Cell Penetration and Cytotoxicity In Vitro."Acs Biomater Sci Eng. 2021;XXXX(XXX):XXX-XXX 69. [IF=7.376] Chengtao Sun et al."Dihydrotanshinone I inhibits ovarian tumor growth by activating oxidative stress through Keap1-mediated Nrf2 ubiquitination degradation."Free Radical Bio Med. 2022 Feb;180:220 68. [IF=1.965] Wang Qian et al."Synthesis, characterization and in vitro anti-proliferative effects of pentacyclic triterpenoids."Med Chem Res. 2021 Nov;30(11):2055-2068 67. [IF=3.411] Kui Ling et al."High-Throughput Screen of Natural Compounds and Biomarkers for NSCLC Treatment by Differential Expression and Weighted Gene Coexpression Network Analysis (WGCNA)."Biomed Res Int. 2021;2021:5955343 66. [IF=3.575] Wenqi Sun et al."Ultrasound targeted microbubble destruction assisted exosomal delivery of miR-21 protects the heart from chemotherapy associated cardiotoxicity."Biochem Bioph Res Co. 2020 Oct;532:60 65. [IF=3.981] Shu Wang et al."Evaluation of novel magnetic targeting microspheres loading adriamycin based on carboxymethyl chitosan."J Drug Deliv Sci Tec. 2020 Feb;55:101388 64. [IF=4.098] Qingying Guo et al."Spectroscopic and cytotoxicity studies on the combined interaction of (?)-epigallocatechin-3-gallate and anthracycline drugs with human serum albumin."Spectrochim Acta A. 2019 Nov;222:117213 63. [IF=4.384] Wenxin Pei et al."High payload and targeted release of anthracyclines by aptamer-tethered DNA nanotrains — Thermodynamic and release kinetic study."Eur J Pharm Sci. 2020 May;148:105319 62. [IF=4.539] Dong-xue Ren et al."pH/redox dual response nanoparticles with poly-γ-glutamic acid for enhanced intracellular drug delivery."Colloid Surface A. 2019 Sep;577:412 61. [IF=5.076] Jingwen Mo et al."An Nd3+-Sensitized Upconversion Fluorescent Sensor for Epirubicin Detection."Nanomaterials-Basel. 2019 Dec;9(12):1700 60. [IF=6.064] Nana Shi et al."Amino-modified carbon dots as a functional platform for drug delivery: Load-release mechanism and cytotoxicity."J Ind Eng Chem. 2021 Sep;101:372 59. [IF=6.165] Yushu Wu et al."Thermodynamics, in vitro release and cytotoxity studies on doxorubicin–toluidine blue O combination drugs co-loaded in aptamer-tethered DNA nanostructures."J Mol Liq. 2020 Dec;320:114390 58. [IF=6.244] Ling Kui et al."High-Throughput In Vitro Gene Expression Profile to Screen of Natural Herbals for Breast Cancer Treatment."Front Oncol. 2021; 11: 684351 57. [IF=6.4] Peng Xu et al."Therapeutic Effect of Doxorubicin-Chlorin E6-Loaded Mesoporous Silica Nanoparticles Combined with Ultrasound on Triple-Negative Breast Cancer."Int J Nanomed. 2020; 15: 2659–2668 56. [IF=6.4] Lijuan Zhang et al."Novel Timosaponin AIII-Based Multifunctional Liposomal Delivery System for Synergistic Therapy Against Hepatocellular Carcinoma Cancer."Int J Nanomed. 2021; 16: 5531–5550 55. [IF=8.579] Zhuo Wan et al."Mononuclear phagocyte system blockade improves therapeutic exosome delivery to the myocardium."Theranostics. 2020; 10(1): 218–230 54. [IF=10.041] Xiangyu Jiao et al."NIR powered Janus nanocarrier for deep tumor penetration."Appl Mater Today. 2020 Mar;18:100504 53. [IF=10.435] Wang Ruoning et al."Synergistic inhibition of metastatic breast cancer by dual-chemotherapy with excipient-free rhein/DOX nanodispersions."J Nanobiotechnol. 2020 Dec;18(1):1-17 52. [IF=10.588] Fangchao Yin et al."A portable digital optical kanamycin sensor developed by surface-anchored liquid crystal droplets."J Hazard Mater. 2021 Oct;420:126601 51. [IF=11.413] Xiaojie Chen et al."Photothermal/matrix metalloproteinase-2 dual-responsive gelatin nanoparticles for breast cancer treatment."Acta Pharm Sin B. 2021 Jan;11:271 50. [IF=1.556] Wei Jiang et al."Synthesis and Characterization of Doxorubicin Loaded pH-Sensitive Magnetic Core–Shell Nanocomposites for Targeted Drug Delivery Applications."Nano. 2016 Oct 20 49. [IF=3.119] Yue Gu et al."Yiqi Fumai lyophilized injection attenuates doxorubicin-induced cardiotoxicity, hepatotoxicity and nephrotoxicity in rats by inhibition of oxidative stress, inflammation and apoptosis."Rsc Adv. 2018 Dec;8(71):40894-40911 48. [IF=3.361] Dandan Xu et al."Combination therapeutics of doxorubicin with Fe3O4@chitosan@phytic acid nanoparticles for multi-responsive drug delivery."Rsc Adv. 2016 Sep;6(91):88248-88254 47. [IF=3.591] Dandan Xu et al."Effect of the synthesis method on the performance of Fe3O4–inositol hexaphosphate as a drug delivery vehicle for combination therapeutics with doxorubicin."New J Chem. 2017 Jun;41(13):5305-5312 46. [IF=4.126] Mengmei Cao et al."Electrochemical and Theoretical Study of π–π Stacking Interactions between Graphitic Surfaces and Pyrene Derivatives."J Phys Chem C. 2014;118(5):2650–2659 45. [IF=4.344] Huang Peng et al."Chemotherapy-driven increases in the CDKN1A/PTN/PTPRZ1 axis promote chemoresistance by activating the NF-κB pathway in breast cancer cells."Cell Commun Signal. 2018 Dec;16(1):1-12 44. [IF=5.155] Juan Wu et al."Synthesis and characterization of recyclable clusters of magnetic nanoparticles as doxorubicin carriers for cancer therapy."Appl Surf Sci. 2014 Dec;321:43 43. [IF=6.057] Jianmei Wang et al."A novel graphene nanodots inlaid porous gold electrode for electrochemically controlled drug release."Talanta. 2016 Jan;147:184 42. [IF=6.331] Wei Zhao et al."Transferrin-decorated, MoS2-capped hollow mesoporous silica nanospheres as a self-guided chemo–photothermal nanoplatform for controlled drug release and thermotherapy."J Mater Chem B. 2017 Sep;5(35):7403-7414 41. [IF=6.331] Zedi Zhang et al."High drug-loading system of hollow carbon dots–doxorubicin: preparation, in vitro release and pH-targeted research."J Mater Chem B. 2019 Mar;7(13):2130-2137 40. [IF=6.331] Fang Wang et al."Cap-free dual stimuli-responsive biodegradable nanocarrier for controlled drug release and chemo-photothermal therapy."J Mater Chem B. 2018 Dec;6(48):8188-8195 39. [IF=6.331] Yaya Cheng et al."Wetting transition in nanochannels for biomimetic free-blocking on-demand drug transport."J Mater Chem B. 2018 Oct;6(39):6269-6277 38. [IF=6.331] Mengni He et al."Fe3O4@carbon@zeolitic imidazolate framework-8 nanoparticles as multifunctional pH-responsive drug delivery vehicles for tumor therapy in vivo."J Mater Chem B. 2015 Nov;3(46):9033-9042 37. [IF=6.988] Li Yu et al."ROS-Responsive Chalcogen-Containing Polycarbonates for Photodynamic Therapy."Biomacromolecules. 2018;19(6):2182–2193 36. [IF=8.355] Shiwei Niu et al."A novel chitosan-based nanomedicine for multi-drug resistant breast cancer therapy."Chem Eng J. 2019 Aug;369:134 35. [IF=8.758] Fang Wang et al."Stimuli-Responsive Nanocarrier for Co-delivery of MiR-31 and Doxorubicin To Suppress High MtEF4 Cancer."Acs Appl Mater Inter. 2018;10(26):22767–22775 34. [IF=8.947] Haoan Wu et al."Injectable magnetic supramolecular hydrogel with magnetocaloric liquid-conformal property prevents post-operative recurrence in a breast cancer model."Acta Biomater. 2018 Jul;74:302 33. [IF=9.229] Zhiguang Wu et al."Biodegradable Protein-Based Rockets for Drug Transportation and Light-Triggered Release."Acs Appl Mater Inter. 2015;7(1):250–255 32. [IF=13.273] Aitang Zhang et al."An efficient and self-guided chemo-photothermal drug loading system based on copolymer and transferrin decorated MoS2 nanodots for dually controlled drug release."Chem Eng J. 2018 Jun;342:120 31. [IF=13.281] Yaya Cheng et al."Free-Blockage Mesoporous Anticancer Nanoparticles Based on ROS-Responsive Wetting Behavior of Nanopores."Small. 2017 Oct;13(40):1701942 30. [IF=13.281] Dongdong Wang et al."Novel Mn3[Co(CN)6]2@SiO2@Ag Core–Shell Nanocube: Enhanced Two-Photon Fluorescence and Magnetic Resonance Dual-Modal Imaging-Guided Photothermal and Chemo-therapy."Small. 2015 Nov;11(44):5956-5967 29. Aitang Zhang, Aihua Li, Wei Zhao, Guowen Yan, Bingping Liu, Mengli Liu, Meixiu Li, Bingbing Huo, Jingquan Liu, An efficient and self-guided chemo-photothermal drug loading system based on copolymer and transferrin decorated MoS2 nanodots for dually control 28. Aitang Zhang, Aihua Li, Wei Zhao, Guowen Yan, Bingping Liu, Mengli Liu, Meixiu Li, Bingbing Huo, Jingquan Liu, An efficient and self-guided chemo-photothermal drug loading system based on copolymer and transferrin decorated MoS2 nanodots for dually control 27. Wu, Haoan, et al. "Injectable magnetic supramolecular hydrogel with magnetocaloric liquid-conformal property prevents post-operative recurrence in a breast cancer model." Acta biomaterialia 74 (2018): 302-311.https://doi.org/10.1016/j.actbio.2018.04.052 26. Shiwei Niu, Gareth R. Williams, Jianrong Wu, Junzi Wu, Xuejing Zhang, Hong Zheng, Shude Li, Li-Min Zhu, A novel chitosan-based nanomedicine for multi-drug resistant breast cancer therapy, Chemical Engineering Journal, Volume 369, 2019, Pages 134-149, ISSN 25. Wu, Zhiguang, et al. "Biodegradable protein-based rockets for drug transportation and light-triggered release." ACS applied materials & interfaces 7.1 (2015): 250-255.https://doi.org/10.1021/am507680u 24. Cheng, Yaya, et al. "Free‐blockage mesoporous anticancer nanoparticles based on ROS‐responsive wetting behavior of nanopores." Small 13.40 (2017): 1701942. 23. Zhang, Zedi, et al. "High drug-loading system of hollow carbon dots–doxorubicin: preparation, in vitro release and pH-targeted research."?Journal of Materials Chemistry B?7.13 (2019): 2130-2137.https://doi.org/10.1039/C9TB00032A 22. Qin, Ye, et al. "MMP-2/9-oriented combinations enhance antitumor efficacy of EGFR/HER2-targeting fusion proteins and gemcitabine." Oncology reports 32.1 (2014): 121-130.https://doi.org/10.3892/or.2014.3169 21. Li Yu, Yue Yang, Fu-Sheng Du, and Zi-Chen Li,ROS-responsive chalcogen-containing polycarbonates for photodynamic therapy, Biomacromolecules 2018 19 (6), 2182-2193 DOI: 10.1021/acs.biomac.8b00271 20. Shiwei Niu, Gareth R. Williams, Jianrong Wu, Junzi Wu, Xuejing Zhang, Hong Zheng, Shude Li, Li-Min Zhu, A novel chitosan-based nanomedicine for multi-drug resistant breast cancer therapy, Chemical Engineering Journal, Volume 369, 2019, Pages 134-149, ISSN 19. Xu P, Yao J, Li Z, et al. Therapeutic Effect of Doxorubicin-Chlorin E6-Loaded Mesoporous Silica Nanoparticles Combined with Ultrasound on Triple-Negative Breast Cancer. Int J Nanomedicine. 2020;15:2659-2668. Published 2020 Apr 21. gttps://doi.org/10.2147/I 18. Zhang, Aitang, et al. "A Target‐Directed Chemo‐Photothermal System Based on Transferrin and Copolymer‐Modified MoS2 Nanoplates with pH‐Activated Drug Release." Chemistry–A European Journal 23.47 (2017): 11346-11356.https://doi.org/10.1002/chem.201701916 17. 尤靜,張文濤,苗延青,張雪嬌,梁玲玲.羧甲基殼聚糖-油酸聚合物的載藥性能及抗腫瘤活性研究[J].化學與生物工程,2021,38(01):22-25+33. 16. 楊濤. 阿霉素聯(lián)合羥基脲誘導大鼠CKD腎陽虛證模型的建立與評價及真武湯干預機制研究[D].北京中醫(yī)藥大學,2020. 15. 0 14. 辛亮亮,舒玥,劉歡,胡雅穩(wěn),楊琳燕.PEG修飾Fe_3O_4納米粒子(MNPs)的制備及載藥研究[J].天津農(nóng)學院學報,2020,27(03):43-48. 13. 程亞亞. 介孔硅基智能藥物控釋體系的構建及在納米醫(yī)學方面的應用[D].北京科技大學,2021. 12. 郭慶英, 劉敏, 趙燕娜, et al. 表沒食子兒茶素沒食子酸酯對柔紅霉素與人血清白蛋白相互作用影響的光譜學及細胞毒性研究[J]. 光譜學與光譜分析, 2020, 040(006):1821-1827. 11. 張忠斌, 李艷華, 沈洪寬,等. 阿霉素納米制劑的制備. 10. 田春艷, 陳蓓, 盧帥,等. 阿霉素體外抗細粒棘球蚴原頭節(jié)作用研究. 9. 張崢嶸, 康冀川, 雷幫星,等. 銀杏內(nèi)生真菌及發(fā)酵液粗提物抗腫瘤活性研究[J]. 山地農(nóng)業(yè)生物學報, 2015, 000(001):52-55. 8. 邢志華. 載阿霉素的葉酸-殼聚糖微球的制備及其體外緩釋性研究[J]. 黑龍江大學自然科學學報, 2012(04):511-514. 7. 馬寧輝, 路璐, 丁越,等. 鹽酸阿霉素和知母皂苷AⅢ共載脂質體的制備及包封率的測定[J]. 中草藥, 2019, 50(01):69-75. 6. 夏錄錄, 李薇, 梅文莉,等. 柬埔寨柯拉斯那沉香中1個新的2-(2-苯乙基)色酮[J]. 中草藥, 2019(20):4863-4866. 5. 朱宏平, 靳高鳳, 陳亞軍,等. 柚皮素對K562/A02細胞MDR1 mRNA/P-gp的影響及機制研究[J]. 中國臨床藥理學與治療學, 2016(11):1209-1214. 4. 高航,趙峰,吳衍,裴文江,鐘明,顧巖,郭善禹,戴謙誠,張偉.微小RNA-9-5p靶向HIC1降低乳腺癌細胞對多柔比星敏感性的研究[J].外科理論與實踐,2020,25(03):227-233. 3. 獨孤佳秀 潘蘭 姜哲 等. 吐魯番錦雞兒地上部分化學成分及體外抗腫瘤活性研究[J]. 新疆醫(yī)科大學學報 2016年39卷10期 1226-1229頁 ISTIC CA 2016. 2. 劉盼盼 陳文. 單分散性介孔二氧化硅的制備及靶向性評價[J]. 中國醫(yī)院藥學雜志 2020年40卷12期 1339-1344頁 ISTIC PKU CA 2020. 1. 閆昕雨 尤靜 余揚 等. 兩親性聚合物制備及其性能的研究[J]. 廣州化工 2019 v.47(12):57-59.

質檢證書(COA)

如何獲取質檢證書(COA)?
請輸入貨號和一個與之匹配的批號。
例如:
批號:C10000001 貨號:A800001-25g
在貨品標簽上如何找到貨號和批號?

摩爾濃度計算器

質量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

=
×
×

相關產(chǎn)品